HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pulmonary complications from monoclonal antibody (OKT3) immunosuppression in patients who have undergone an orthotopic liver transplant].

Abstract
The authors investigated the incidence of pulmonary complications following immunosuppression with monoclonal antibodies (OKT3) in a series of 100 consecutive cases of orthotopic liver transplantation (OLT). Of 17 patients treated with OKT3 (16 for acute rejection and 1 for cyclosporine toxicity), 11 pulmonary infections were observed (65%), 9 of which (53%) with onset within a mean of 9 days after OKT3 administration. The infections were severe in all cases and lethal in 8 cases: the most common pathogens were Candida (4 cases) and Pseudomonas aeruginosa (3 cases). On the contrary, of 39 cases of rejection treated with steroids, infections were observed in 3 cases only (8%). The 53% incidence of pulmonary infections in OKT3 patients, significantly higher than in the extant patients (19%), confirms OKT3 treatment as a strong risk factor for severe pulmonary infections. Furthermore, the occurrence of pulmonary edema was directly related to OKT3 administration in 7 OKT3 patients (41%), whereas only 20 cases (24%) occurred in the extant OLT patients (p < 0.001). OKT3-related pulmonary edema was always observed in hyperhydrated patients at the time of drug administration and it seemed to be related to the vasoactive myocardiotoxic agents released by damaged T-cells.
AuthorsR Golfieri, E Giampalma, A Lalli, C Sama, N Venturoli, A Mazziotti, G Gozzetti, G Gavelli
JournalLa Radiologia medica (Radiol Med) 1994 Jan-Feb Vol. 87 Issue 1-2 Pg. 58-64 ISSN: 0033-8362 [Print] Italy
Vernacular TitleComplicanze polmonari da immunosoppressione con anticorpi monoclonali (OKT3) nei pazienti sottoposti a trapianto ortotopico di fegato.
PMID8128034 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Muromonab-CD3
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Child
  • Graft Rejection (diagnosis, epidemiology, etiology, prevention & control)
  • Humans
  • Immunosuppression Therapy (adverse effects, methods, statistics & numerical data)
  • Incidence
  • Italy (epidemiology)
  • Liver Transplantation (statistics & numerical data)
  • Lung Diseases (diagnosis, epidemiology, etiology)
  • Middle Aged
  • Muromonab-CD3 (administration & dosage, adverse effects)
  • Postoperative Complications (diagnosis, epidemiology, etiology)
  • Pulmonary Edema (diagnosis, epidemiology, etiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: